» Authors » Carine Kirkove

Carine Kirkove

Explore the profile of Carine Kirkove including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 875
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaidar-Person O, Boersma L, De Brouwer P, Weltens C, Kirkove C, Peignaux-Casasnovas K, et al.
Radiother Oncol . 2024 Sep; 201:110563. PMID: 39341505
Material/methods: Data with a median follow-up of 15.7 years were extracted from the trial's case report forms. Kaplan-Meier curves of disease-free and OS and cumulative incidence curves of breast cancer...
2.
Kaidar-Person O, Giasafaki P, Boersma L, De Brouwer P, Weltens C, Kirkove C, et al.
Radiother Oncol . 2023 May; 185:109698. PMID: 37211281
Patients And Methods: All data were extracted from the trial's individual patients' case report forms (CRF) and analysed with a median follow-up of 15.7 years. Cumulative incidence curves were produced...
3.
Vander Veken L, Van Ooteghem G, Razavi A, Da Rita Quaresma S, Longton E, Kirkove C, et al.
Radiother Oncol . 2023 Mar; 183:109598. PMID: 36898583
Background And Purpose: Deep inspiration breath-hold (DIBH) protects critical organs-at-risk (OARs) for adjuvant breast radiotherapy. Guidance systems e.g. surface guided radiation therapy (SGRT) improve the positional breast reproducibility and stability...
4.
Chua B, Link E, Kunkler I, Whelan T, Westenberg A, Gruber G, et al.
Lancet . 2022 Aug; 400(10350):431-440. PMID: 35934006
Background: Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after WBI improved outcomes, and examined...
5.
Kaidar-Person O, Fortpied C, Hol S, Weltens C, Kirkove C, Budach V, et al.
Radiother Oncol . 2022 May; 172:99-110. PMID: 35568284
Background And Purpose: The multicentre EORTC 22922/10925 trial (ClinicalTrials.gov, NCT00002851) was conducted between 1996 and 2004. The trial evaluated the effect of irradiation of the internal mammary and medial supraclavicular...
6.
Ahrouch I, Van Gestel D, Koshariuk O, Kirkove C, Desmet A, Philippson C, et al.
Radiother Oncol . 2021 Oct; 164:282-288. PMID: 34648872
Background And Purpose: To evaluate dosimetric differences in unintended dose to the lower axilla between 3D-standard (3DCRT), tangential beam forward intensity modulated radiotherapy (F-IMRT) and volumetric modulated arc therapy (VMAT)....
7.
Poortmans P, Struikmans H, De Brouwer P, Weltens C, Fortpied C, Kirkove C, et al.
J Natl Cancer Inst . 2021 Jul; 113(10):1360-1368. PMID: 34320651
Background: Uncertainty about the benefit-risk ratio of regional lymph node irradiation led to varying clinical protocols. We investigated long-term late side effects after internal mammary and medial supraclavicular (IM-MS) lymph...
8.
Poortmans P, Weltens C, Kirkove C
Lancet Oncol . 2021 Feb; 22(2):e41. PMID: 33539748
No abstract available.
9.
Poortmans P, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, et al.
Lancet Oncol . 2020 Nov; 21(12):1602-1610. PMID: 33152277
Background: 10-year results from several studies showed improved disease-free survival and distant metastasis-free survival, reduced breast cancer-related mortality, and variable effects on overall survival with the addition of partial or...
10.
Olivotto I, Link E, Phillips C, Whelan T, Bryant G, Kunkler I, et al.
Radiother Oncol . 2019 Aug; 142:180-185. PMID: 31431385
Purpose: To assess the cosmetic impact of breast conserving surgery (BCS), whole breast irradiation (WBI) fractionation and tumour bed boost (TBB) use in a phase III trial for women with...